Intraabdominal infections are a wide range of diseases that include pe
netrating abdominal trauma, appendicitis, peritonitis, and abscess. Mo
st are polymicrobic, involving aerobic and anaerobic bacteria. The pri
mary treatment is surgery, but important issues regarding administrati
on of antimicrobials may affect patient outcome. Evaluation of an anti
microbial regimen must include consideration of outcomes-survival, org
an failure, adverse drug effects, and superinfection. Single-agent reg
imens have demonstrated benefit in patients with acute intraabdominal
contamination and established infections. Guidelines for selecting ant
imicrobial agents are available from the Surgical Infection Society. R
egimens are effective when active against most bacteria isolated from
the focus of abdominal infection. The patient's clinical response, not
culture results independent of clinical findings, is the primary guid
e for directing changes in therapy.